Arrowhead Pharmaceuticals Inc (ARWR) — Defensive Interval Ratio
Arrowhead Pharmaceuticals Inc (ARWR) has a Defensive Interval Ratio of 1564 days as of September 2025. Defensive assets of $837.48 Million (cash $-, short-term investments $830.66 Million, receivables $6.82 Million) cover 1564 days of daily cash needs of $535.58K/day. Check Arrowhead Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Arrowhead Pharmaceuticals Inc Defensive Interval Ratio (1997–2025)
This chart shows how Arrowhead Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 27 annual periods from 1997 to 2025. As of September 2025, the ratio stands at 1564 days, meaning defensive assets of $837.48 Million can fund 1564 days of operations without new revenue. Also explore Arrowhead Pharmaceuticals Inc net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Arrowhead Pharmaceuticals Inc (1997–2025)
The table below presents the year-by-year Defensive Interval Ratio for Arrowhead Pharmaceuticals Inc from 1997 to 2025, covering 27 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Arrowhead Pharmaceuticals Inc stock valuation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1306 days | $699.64 Million | $535.58K/day | $- | $692.82 Million | ▼ -740 days |
| 2024 | 2046 days | $578.28 Million | $282.65K/day | $- | $578.28 Million | ▲ +1033 days |
| 2023 | 1013 days | $292.74 Million | $288.92K/day | $- | $292.74 Million | ▲ +304 days |
| 2022 | 709 days | $269.80 Million | $380.41K/day | $- | $268.39 Million | ▲ +227 days |
| 2021 | 482 days | $193.61 Million | $401.47K/day | $- | $183.35 Million | ▼ -1068 days |
| 2020 | 1550 days | $172.76 Million | $111.46K/day | $- | $171.91 Million | ▲ +1409 days |
| 2019 | 141 days | $37.56 Million | $265.95K/day | $- | $36.90 Million | ▼ -1238 days |
| 2018 | 1379 days | $46.73 Million | $33.88K/day | $- | $46.40 Million | ▲ +582 days |
| 2017 | 797 days | $40.84 Million | $51.24K/day | $- | $40.77 Million | ▲ +796 days |
| 2016 | 1 days | $75.00K | $70.26K/day | $- | $0.00 | ▼ -403 days |
| 2015 | 404 days | $17.61 Million | $43.56K/day | $- | $17.54 Million | ▼ -265 days |
| 2014 | 669 days | $21.73 Million | $32.46K/day | $- | $21.65 Million | ▲ +288 days |
| 2013 | 381 days | $9.11 Million | $23.90K/day | $- | $9.03 Million | ▲ +205 days |
| 2012 | 176 days | $2.57 Million | $14.60K/day | $- | $106.50K | ▼ -141 days |
| 2011 | 317 days | $2.24 Million | $7.07K/day | $- | $634.59K | ▲ +238 days |
| 2010 | 79 days | $930.68K | $11.72K/day | $- | $- | ▲ +57 days |
| 2009 | 23 days | $147.26K | $6.42K/day | $- | $- | ▲ +14 days |
| 2008 | 8 days | $86.60K | $10.21K/day | $- | $- | ▼ -26 days |
| 2007 | 35 days | $276.06K | $7.94K/day | $- | $- | ▲ +26 days |
| 2006 | 9 days | $74.21K | $8.00K/day | $- | $- | ▼ -30 days |
| 2005 | 39 days | $110.33K | $2.81K/day | $- | $76.88K | ▼ -246 days |
| 2004 | 286 days | $539.72K | $1.89K/day | $- | $487.89K | ▲ +285 days |
| 2001 | 0 days | $640.00 | $3.61K/day | $- | $- | ▼ 0 days |
| 2000 | 0 days | $1.28K | $3.17K/day | $- | $- | ▼ -4 days |
| 1999 | 4 days | $11.30K | $2.84K/day | $- | $- | ▲ +4 days |
| 1998 | 0 days | $3.17K | $7.31K/day | $- | $- | ▼ -1 days |
| 1997 | 1 days | $10.42K | $7.35K/day | $- | $- | — |